Erratum to Specificity of a protein-protein interface: Local dynamics direct substrate recognition of effector caspases [PROTEINS: Structure, Function, and Bioinformatics 82(4)(2014) 546-555] DOI:10.1002/prot.24417;Specificity of a protein-protein interface: Local dynamics direct substrate recognition of effector caspases

Proteins: Structure, Function and Bioinformatics

Volumn 82, Issue 4, 2014, Pages 546-555

  Fuchs, Julian E ^a   von Grafenstein, Susanne ^a   Huber, Roland G ^a   Wallnoefer, Hannes G ^a   Liedl, Klaus R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Caspase; Conformational selection; Local dynamics; Protein protein interface; Specificity; Substrate recognition

Indexed keywords

CASPASE; CASPASE 3; CASPASE 7; CYSTEINE PROTEINASE; EFFECTOR CASPASE; PROLINE; PROTEINASE;

APOPTOSIS; ARTICLE; BINDING SITE; COMPUTER MODEL; CONFORMATIONAL TRANSITION; CORRELATION ANALYSIS; DATA MINING; ENZYME SPECIFICITY; HUMAN; INFLAMMATION; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RIGIDITY;

CASPASE; CONFORMATIONAL SELECTION; LOCAL DYNAMICS; PROTEIN-PROTEIN INTERFACE; SPECIFICITY; SUBSTRATE RECOGNITION;

APOPTOSIS; BINDING SITES; CASPASE 3; CASPASE 7; CATALYTIC DOMAIN; DATABASES, PROTEIN; INFLAMMATION; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; SUBSTRATE SPECIFICITY;

EID: 84895560474     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.24660     Document Type: Erratum

References (81)

1. Frederick KK, Marlow MS, Valentine KG, Wand AJ. Conformational entropy in molecular recognition by proteins. Nature 2007;448:325-330.
2. Janin J. Principles of protein-protein recognition from structure to thermodynamics. Biochimie 1995;77:497-505.
3. Kysilka J, Vondrasek, J. Towards a better understanding of the specificity of protein-protein interaction. J Mol Recognit 2012;25:604-615.
4. Henzler-Wildman K, Kern D. Dynamic personalities of proteins. Nature 2007;450:964-972.
5. Lange OF, Lakomek NA, Fares C, Schröder GF, Walter KFA, Becker S, Meiler J, Grubmueller H, Griesinger C, de Groot BL. Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin ensemble in solution. Science 2008;320:1471-1475.
6. Boehr DD, Nussinov R, Wright PE. The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 2009;5:789-796.
7. Mittag T, Kay LE, Forman-Kay JD. Protein dynamics and conformational disorder in molecular recognition. J Mol Recognit 2010;23:105-116.
8. Ma B, Shatsky M, Wolfson HJ, Nussinov R. Multiple diverse ligands binding at a single protein site: a matter of pre-exisiting populations. Protein Sci 2002;11:184-197.
9. Tsai CJ, Kumar S, Ma B, Nussinov R. Folding funnels, binding funnels, and protein function. Protein Sci 1999;8:1181-1190.
10. Otlewski J, Jelen F, Zakrzewska M, Oleksy A. The many faces of protease-protein inhibitor interaction. EMBO J 2005;24:1303-1310.
11. Perona JJ, Craik CS. Structural basis of substrate specificity in the serine proteases. Protein Sci 1995;4:337-360.
12. Schilling O, Overall CM. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol 2008;26:685-694.
13. Poreba M, Drag M. Current strategies for probing substrate specificity of proteases. Curr Med Chem 2010;17:3968-3995.
14. O'Donoghue AJ, Eroy-Reveles AA, Knudsen GM, Ingram J, Zhou M, Statnekov JB, Greninger AL, Hostetter DR, Qu G, Maltby DA, Anderson MO, DeRisi JL, McKerrow JH, Burlingame AL, Craik CS. Global identification of peptidase specificity by multiplex substrate profiling. Nat Methods 2012;9:1095-1103.
15. Fuchs JE, von Grafenstein S, Huber RG, Margreiter MA, Spitzer GM, Wallnoefer HG, Liedl KR. Cleavage entropy as quantitative measure of protease specificity. PLOS Comput Biol 2013;9:e1003007.
16. Pop C, Salvesen GS. Human caspases: activation, specificity, and regulation. J Biol Chem 2009;284:21777-21781.
17. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
18. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
19. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005;115:2665-2672.
20. Yoshimori A, Sakai J, Sunaga S, Kobayashi T, Takahashi S, Okita N, Takasawa R, Tanuma S. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO. BMC Pharmacol 2007;7:8.
21. Fuentes-Prior P, Salvesen GS. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem J 2004;382:201-232.
22. Feeney B, Pop C, Swartz P, Mattos C, Clark AC. Role of loop bundle hydrogen bonds in the maturation and activity of (Pro)caspase-3. Biochemistry 2006;45:13249-13263.
23. Chai J, Wu Q, Shiozaki E, Srinivasula SM, Alnemri ES, Shi Y. Crystal Structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 2001;107:399-407.
24. Ni CZ, Li C, Wu JC, Spada AP, Ely KR. Conformational restrictions in the active site of unliganded human caspase-3. J Mol Recognit 2003;16:121-124.
25. Agniswamy J, Fang B, Weber IT. Conformational similarity in the activation of caspase-3 and -7 revealed by the unliganded and inhibited structures of caspase-7. Apoptosis 2009;14:1135-1144.
26. Putt KS, Chen GW, Pearson JM, Sandhorst JS, Hoagland MS, Kwon JT, Hwang SK, Jin H, Churchwell MI, Cho MH, Doerge DR, Helferich WG, Hergenrother PJ. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol 2006;2:543-550.
27. Schipper JL, MacKenzie SH, Sharma A, Clark AC. A bifunctional allosteric site in the dimer interface of procaspase-3. Biophys Chem 2011;159:100-109.
28. Wei T, Fox T, Chambers SP, Sintchak JA, Coll JT, Golec JMC, Swenson L, Wilson KP, Charifson PS. The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. Chem Biol 2000;7:423-432.
29. Walsh JG, Logue SE, Luethi AU, Martin SJ. Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme. J Biol Chem 2011;286:32513-32524.
30. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J Biol Chem 1997;272:17907-17911.
31. Stennicke HR, Renatus M, Meldal M, Salvesen GS. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem J 2000;350:563-568.
32. Benkova B, Lozanov V, Ivanov IP, Mitev, V. Evaluation of recombinant caspase specificity by competitive substrates. Anal Biochem 2009;394:68-74.
33. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD, Wong WW. Substrate specificities of caspase family proteases. J Biol Chem 1997;272:9677-9682.
34. Lakhani SA, Masud A, Kuida K, Porter GA, Jr., Booth CJ, Mehal WZ, Inayat I, Flavell RA. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006;311:847-851.
35. Kuida K, Zheng TS, Na S, Kuan CY, Yang D, Karasuyama H, Rakic P, Flavell RA. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996;384:368-372.
36. Houde C, Banks KG, Coulombe N, Rasper D, Grimm E, Roy S, Simpson EM, Nicholson DW. Caspase-7 expanded function and intrinsic expression level underlies strain-specific brain phenotype of caspase-3-null mice. J Neurosci 2004;24:9977-9984.
37. Demon D, van Damme P, Vandenberghe T, Vandekerckhove J, Declercq W, Gevaert K, Vandenabeele P. Caspase substrates: easily caught in deep waters? Trends Biotechnol 2009;27:680-688.
38. Luethi AU, Martin SJ. The CASBAH: a searchable database of caspase substrates. Cell Death Differ 2007;14:641-650.
39. Walsh JG, Cullen SP, Sheridan C, Luethi AU, Gerner C, Martin SJ. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci USA 2008;105:12815-12819.
40. Demon D, van Damme P, Vandenberghe T, Deceuninck A, van Durme J, Verspurten J, Helsens K, Impens F, Wejda M, Schymkowitz J, Rousseau F, Madder A, Vandekerckhove J, Declercq W, Gevaert K, Vandenabeele P. Proteome-wide substrate analysis indicates substrate exclusion as a mechanism to generate caspase-7 Versus caspase-3 specificity. Mol Cell Proteomics 2009;8:2700-2714.
41. Agniswamy J, Fang B, Weber IT. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis. FEBS J 2007;274:4752-4765.
42. Crawford ED, Wells JA. Caspase substrates and cellular remodeling. Annu Rev Biochem 2011;80:1055-1087.
43. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell 2008;134:866-876.
44. Wee LJ, Tan TW, Ranganathan, S. SVM-based prediction of caspase substrate cleavage sites. BMC Bioinformatics 2010;7 (Suppl 5):S14.
45. Barkan DT, Hostetter DR, Mahrus S, Pieper U, Wells JA, Craik CS, Sali A. Prediction of protease substrates using sequence and structure features. Bioinformatics 2010;26:1714-1722.
46. Song J, Tan H, Shen H, Mahmood K, Boyd SE, Webb GI, Akutsu T, Whisstock JC. Cascleave: towards more accurate prediction of caspase substrate cleavage sites. Bioinformatics 2010;26:752-760.
47. Maillard MC, Brookfield FA, Courtney SM, Eustache FM, Gemkow MJ, Handel RK, Johnson LC, Johnson PD, Kerry MA, Krieger F, Meniconi M.; Munoz-Sanjuan I, Palfrey JJ, Park H, Schaertl S, Taylor MG, Weddell D, Dominguez C. Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors. Bioorg Med Chem 2011;19:5833-5851.
48. Yoshimori A, Takasawa R, Tanuma S. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score. BMC Pharmacol 2004;4:7.
49. Fu G, Chumanevich AA, Agniswamy J, Fang B, Harrison RW, Weber IT. Structural basis for executioner caspase recognition of P5 position in substrates. Apoptosis 2008;13:1291-1302.
50. Fang B, Fu G, Agniswamy J, Harrison RW, Weber IT. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallographic and structural modeling. Apoptosis 2009;14:741-752.
51. Hensen U, Meyer T, Haas J, Rex R, Vriend G, Grubmueller, H. Exploring protein dynamics space: the dynasome as the missing link between protein structure and function. PLOS One 2012;7:e33931.
52. Piana S, Rothlisberger U. Molecular dynamics simulations of structural changes during procaspase 3 activation. Proteins 2004;55:932-941.
53. Piana S, Taylor Z, Rothlisberger, U. Folding pathways for initiator and effector procaspases from computer simulations. Proteins 2005;59:765-772.
54. Sulpizi M, Rothlisberger U, Carloni, P. Molecular dynamics studies of caspase-3. Biophys J 2003;84:2207-2215.
55. Walters J, Schipper WL, Swartz P, Mattos C, Clar AC, Allosteric modulation of caspase 3 through mutagenesis. Biosci Rep 2012;32:401-411.
56. Savitsky AP, Rusanov AL, Zherdeva VV, Gorodnichewa TV, Khrenova MG, Nemukhin AV. FLIM-FRET imaging of caspase-3 activitity in live cells using pair of red fluorescent proteins. Theranostics 2012;2:215-226.
57. Rawlings ND, Barrett AJ, Bateman A. MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 2012;40:D343-D350.
58. Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA, Becker JW. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat Struct Biol 1993;3:619-625.
59. DeLano WL. The Pymol molecular graphics system, version 1.5.0.2. San Carlos, CA: DeLano Scientific; 2008.
60. Molecular Operating Environment (MOE), version 2011.10. Montreal, Canada: Chemical Computing Group, Inc.; 2011.
61. Labute P. Protonate 3D: assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins 2009;75:187-205.
62. Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Crowley M, Walker RC, Zhang W, Merz KM, Wang B, Hayik S, Roitberg A, Seabra G, Kolossváry I, Wong KF, Paesani F, Vanicek J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Yang L, Tan C, Mongan J, Hornak V, Cui G, Mathews DH, Seetin MG, Sagui C, Babin V, Kollman PA. AMBER 10. San Francisco, CA: University of California; 2008.
63. Jorgensen WL, Chandrasekhar J, Madura J, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926-935.
64. Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 2010;78:1950-1958.
65. Darden T, York D, Pedersen, L. Particle mesh Ewald: an N*log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089-10092.
66. Wallnoefer HG, Handschuh S, Liedl KR, Fox T. Stabilizing of a globular protein by a highly complex water network: a molecular dynamics study on factor Xa. J Phys Chem B 2010;114:7405-7412.
67. Adelman SA, Doll JD. Generalized Langevin equation approach for atom-solid-surface scattering-general formulation for classical scattering off harmonic solids. J Chem Phys 1976;64:2375-2388.
68. Ciccotti G, Ryckaert JP. Molecular dynamics simulation of rigid molecules. Comput Phys Rep 1986;4:345-392.
69. Perona JJ, Craik CS. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J Biol Chem 1997;272:29987-29990.
70. Hedstrom L, Szilagyi L, Rutter WJ. Converting trypsin to chymotrypsin-the role of surface loops. Science 1992;255:1249-1253.
71. Ma W, Tang C, Lai L. Specificity of trypsin and chymotrypsin: loop-motion-controlled dynamic correlation as a determinant. Biophys J 2005;89:1183-1193.
72. Gaspari Z, Varnai P, Szappanos B, Perczel A. Reconciling the lock-and-key and dynamic views of canonical serine protease inhibitor action. FEBS Lett 2010;584:203-206.
73. Lechtenberg BC, Johnson DJ, Freund SM, Huntington JA. NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation. Proc Natl Acad Sci USA 2010;107:14087-14092.
74. Huntington JA. Thrombin plasticity. Biochim Biophys Acta 2012;1824:246-252.
75. Mace JE, Wilk BJ, Agard DA. Functional linkage between the active site of alpha-lytic protease and distant regions of structure: scanning alanine mutagenesis of a surface loop affects activity and substrate specificity. J Mol Biol 1995;251:116-134.
76. Mace JE, Agard DA. Kinetic and structural characterization of mutations of glycine 216 in alpha-lytic protease: a new target for engineering substrate specificity. J Mol Biol 1995;254:720-736.
77. Ozen A, Haliloglu T, Schiffer CA. Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope. J Mol Biol 2011;410:726-744.
78. Mulder FA, Schipper D, Bott R, Boelens R. Altered flexibility in the substrate-binding site of related native and engineered high-alkaline Bacillus subtilisins. J Mol Biol 1999;292:111-123.
79. Wallnoefer HG, Lingott T, Gutierrez JM, Merfort I, Liedl KR. Backbone flexibility controls the activity and specificity of a protein-protein interface: specificity in snake venom metalloproteases. J Am Chem Soc 2010;132:10330-10337.
80. Carnevale V, Raugei S, Micheletti C, Carloni P. Convergent dynamics in the protease enzymatic superfamily. J Am Chem Soc 2006;128:9766-9772.
81. Hedstrom L. Serine protease mechanism and specificity. Chem Rev 2002;102:4501-4524.